Biotech tax break is latest plan to revive US pharma
A Bill with versions in the US Senate and House of Representatives provides tax breaks for life sciences research and investment in the hope of creating jobs, despite criticism that similar efforts have backfired in the past.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: